← Back to Search

Oxygen Therapy

Titration of nocturnal oxygen needs to prevent desaturations for Chronic Heart Failure (HO2F Trial)

Phase 4
Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months ( titration completed 3 times during the study period)
Awards & highlights

Summary

This trial is testing different levels of oxygen flow during sleep in order to minimize oxygen desaturation while also minimizing periods of hyperoxia.

Eligible Conditions
  • Chronic Heart Failure
  • Central Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months ( titration completed 3 times during the study period)
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months ( titration completed 3 times during the study period) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Accuracy of automated oxygen titration
Changes in optimal levels of O2 flow ( EO2F) which prevent nocturnal O2 desaturation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Oxygen therapyExperimental Treatment1 Intervention
Fixed nightime oxygen therapy throughout the protocol duration

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
423 Previous Clinical Trials
173,014 Total Patients Enrolled
OxynovUNKNOWN
Philips RespironicsIndustry Sponsor
66 Previous Clinical Trials
9,617 Total Patients Enrolled
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top